These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 6370314

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The binding of 125I-insulin to specific receptors in IM-9 human lymphocytes. Detection of radioactivity covalently linked to receptors.
    Saviolakis GA, Harrison LC, Roth J.
    J Biol Chem; 1981 May 25; 256(10):4924-8. PubMed ID: 7014566
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Insulin receptors of cultured human lymphocytes (IM-9). Lack of receptor-mediated degradation.
    Sonne O, Gliemann J.
    J Biol Chem; 1980 Aug 10; 255(15):7449-54. PubMed ID: 6993488
    [Abstract] [Full Text] [Related]

  • 25. Tyrosine A14[125I]monoiodoinsulin: Preparation, Biologic Properties, and long-term stability.
    Linde S, Hansen B, Sonne O, Holst JJ, Gliemann J.
    Diabetes; 1981 Jan 10; 30(1):1-8. PubMed ID: 7014299
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Receptor binding properties and biologic activity in vitro of biosynthetic human insulin.
    Keefer LM, Piron MA, De Meyts P.
    Diabetes Care; 1981 Jan 10; 4(2):209-14. PubMed ID: 7011729
    [Abstract] [Full Text] [Related]

  • 28. Interactions of a monoclonal antibody to the insulin receptor with receptors for insulin-like growth factors.
    Roth RA, Maddux B, Wong KY, Styne DM, Van Vliet G, Humbel RE, Goldfine ID.
    Endocrinology; 1983 May 10; 112(5):1865-7. PubMed ID: 6299712
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Insulin receptor degradation is accelerated in cultured lymphocytes from patients with genetic syndromes of extreme insulin resistance.
    McElduff A, Hedo JA, Taylor SI, Roth J, Gorden P.
    J Clin Invest; 1984 Oct 10; 74(4):1366-74. PubMed ID: 6480829
    [Abstract] [Full Text] [Related]

  • 32. Relationship of insulin binding to amino acid transport by cultured 14-day embryonic chick heart cells.
    Santora AC, Wheeler FB, DeHaan RL, Elsas LJ.
    Endocrinology; 1979 Apr 10; 104(4):1059-68. PubMed ID: 436747
    [Abstract] [Full Text] [Related]

  • 33. Polar redistribution of 125I-labelled insulin on the plasma membrane of cultured human lymphocytes.
    Barazzone P, Carpentier JL, Gorden P, Van Obberghen E, Orci L.
    Nature; 1980 Jul 24; 286(5771):401-3. PubMed ID: 6995853
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Consequences of 125I-labeled insulin degradation by hepatocytes on the interpretation of receptor binding studies.
    McCaleb M, Donner DB.
    Biochim Biophys Acta; 1982 Apr 29; 720(2):147-53. PubMed ID: 7044427
    [Abstract] [Full Text] [Related]

  • 36. Uptake and metabolic fate of [HisA8,HisB4,GluB10,HisB27]insulin in rat liver in vivo.
    Authier F, Di Guglielmo GM, Danielsen GM, Bergeron JJ.
    Biochem J; 1998 Jun 01; 332 ( Pt 2)(Pt 2):421-30. PubMed ID: 9601071
    [Abstract] [Full Text] [Related]

  • 37. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the insulin B-chain. Preparation and characterization of some binding properties.
    Linde S, Sonne O, Hansen B, Gliemann J.
    Hoppe Seylers Z Physiol Chem; 1981 Jun 01; 362(6):573-9. PubMed ID: 7024083
    [Abstract] [Full Text] [Related]

  • 38. Qualitative abnormalities in insulin binding in a patient with extreme insulin resistance: decreased sensitivity to alterations in temperature and pH.
    Taylor SI, Roth J, Blizzard RM, Elders MJ.
    Proc Natl Acad Sci U S A; 1981 Nov 01; 78(11):7157-61. PubMed ID: 7031672
    [Abstract] [Full Text] [Related]

  • 39. Evidence for presence of insulin receptors in rat islets of Langerhans.
    Verspohl EJ, Ammon HP.
    J Clin Invest; 1980 May 01; 65(5):1230-7. PubMed ID: 6988459
    [Abstract] [Full Text] [Related]

  • 40. Intracellular potassium depletion in IM-9 lymphocytes suppresses the slowly dissociating component of human growth hormone binding and the down-regulation of its receptors but does not affect insulin receptors.
    Ilondo MM, Courtoy PJ, Geiger D, Carpentier JL, Rousseau GG, De Meyts P.
    Proc Natl Acad Sci U S A; 1986 Sep 01; 83(17):6460-4. PubMed ID: 3018733
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.